Novartis drug Pelacarsen that targets Lp(a) cholesterol is in global phase 3 trials. Last year, the company launched ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have ...

Here is how you can save yourself from the serious impacts of high cholesterol. From choosing the right foods to staying ...

Munching pecan nuts instead of crisps or sweets may reduce the risk of a heart attack or stroke, according to research ...

Verve Therapeutics shares rose sharply in premarket trading Monday after the clinical-stage genetic-medicines company reported positive early study data for its Verve-102 gene-editing drug targeting a ...

The focus is on a drug called Lepodisiran, that could target certain factors that increase risk of heart attacks and strokes.

Learn more about whether Ionis Pharmaceuticals, Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's ...

New studies focus on a more balanced, plant-forward approach, finding that a diet high in plants (fruits, vegetables and ...

Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) ...